CTAG1A Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P78358 |
---|---|
Clone Names | 100324117 |
Gene ID | 1485;246100 |
---|---|
Other Names | Cancer/testis antigen 1, Autoimmunogenic cancer/testis antigen NY-ESO-1, Cancer/testis antigen 61, CT61, L antigen family member 2, LAGE-2, CTAG1A, CTAG, CTAG1, ESO1, LAGE2, LAGE2A |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13527a was selected from the N-term region of CTAG1A. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CTAG1A |
---|---|
Synonyms | CTAG, CTAG1, ESO1, LAGE2, LAGE2A |
Cellular Location | Cytoplasm. |
Tissue Location | Expressed in testis and ovary and in a wide variety of cancers. Detected in uterine myometrium. Expressed from 18 weeks until birth in human fetal testis. In the adult testis, is strongly expressed in spermatogonia and in primary spermatocytes, but not in post-meiotic cells or in testicular somatic cells (at protein level) |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
CTAG1A is an identical copy of the CTAG1B gene (MIM300156) (Aradhya et al., 2001 [PubMed 11709543]).[supplied byOMIM].
References
Yoshida, N., et al. Int. J. Oncol. 28(5):1089-1098(2006)Cho, H.J., et al. Cancer Immun. 6, 12 (2006) :Ross, M.T., et al. Nature 434(7031):325-337(2005)Scanlan, M.J., et al. Immunol. Rev. 188, 22-32 (2002) :Satie, A.P., et al. Lab. Invest. 82(6):775-780(2002)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.